NATHAN A. BEATON is an associate at Latham & Watkins LLP where he focuses his practice on regulatory and transactional matters involving the healthcare and life sciences industries. Mr. Beaton counsels clients on matters involving the Food and Drug Administration (FDA), Department of Health & Human Services Office of Inspector General, Centers for Medicare & Medicaid Services, Federal Trade Commission, and other governmental authorities. Mr. Beaton has experience advising clients in all stages of the biotechnology product life cycle, including pre-market regulatory communications and submissions, contract matters relating to clinical trials, promotion and labeling, compliance with the Quality System Regulation and Good Manufacturing Practice requirements, reimbursement strategy, post-market inspections and recalls, and administrative appeals. He also advises financial institutions, healthcare providers and suppliers, and pharmaceutical, medical device, and biotechnology companies on healthcare and FDA regulatory matters in connection with mergers and acquisitions, equity offerings, financings, and other transactions. Mr. Beaton earned his Juris Doctor from the University of Chicago Law School, with honors, and his Master of Public Policy from the University of Chicago Harris School, with a Certificate in Health Policy. While in law school, he served as a legal intern at Ann & Robert H. Lurie Children’s Hospital, and participated in the Law School’s Corporate Lab, a transactional-focused legal clinic.